Back to results
US 11,957,647 B2Granted
Pharmaceutical composition comprising adrenaline
AssigneeOrexo AB
InventorsJonas Sävmarker, Robert Rönn
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeOrexo AB
InventorsJonas Sävmarker, Robert Rönn
Estimating the term…
Disclosed is a pharmaceutically-acceptable composition in the form of a solid, amorphous, mono-particulate powder comprising a mixture of: (a) a pharmacologically-effective dosage amount of an adrenergic receptor modulator, or a pharmaceutically-acceptable salt thereof; and (b) a pharmaceutically-acceptable carrier material, which carrier material comprises a maltodextrin with a dextrose equivalent (DE) that is above 15. Compositions are suitable for transmucosal drug delivery, including nasal delivery, by which said compositions may be loaded into a single-use nasal applicator. Compositions are preferably made by way of spray drying and may further include a disaccharide, such as lactose or trehalose which, along with the active ingredient and maltodextrin, may be spray-dried together in combination. Compositions may further comprise one or more alkyl saccharides. Preferred alkyl saccharides include sucrose esters, such as sucrose monolaurate. Preferred adrenergic receptor modulators include epinephrine (adrenaline). The compositions are thus particularly useful in the treatment of allergic reactions, including anaphylaxis.
A pharmaceutically-acceptable composition in the form of a solid, amorphous, mono-particulate powder comprising a mixture of:
A pharmaceutically-acceptable composition in the form of an amorphous spray-dried powder, comprising a mixture of:
A nasal applicator device suitable and/or adapted for delivery of a pharmaceutically-acceptable composition to the nose, which composition is in the form of a spray-dried powder with a particle size distribution that comprises a D10 above about 10 μm and a D90 below about 100 μm, which composition comprises a mixture of:
Dependencies are inferred from the claim text.